47 related articles for article (PubMed ID: 31215288)
21. Phytosterols and triterpenes from Morinda lucida Benth. exhibit binding tendency against class I HDAC and HDAC7 isoforms.
Ishola AA; Adewole KE
Mol Biol Rep; 2019 Apr; 46(2):2307-2325. PubMed ID: 30771146
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.
Richard DJ; Lena R; Bannister T; Blake N; Pierceall WE; Carlson NE; Keller CE; Koenig M; He Y; Minond D; Mishra J; Cameron M; Spicer T; Hodder P; Cardone MH
Bioorg Med Chem; 2013 Nov; 21(21):6642-9. PubMed ID: 23993674
[TBL] [Abstract][Full Text] [Related]
24. Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins.
Mohamad Rosdi MN; Mohd Arif S; Abu Bakar MH; Razali SA; Mohamed Zulkifli R; Ya'akob H
Apoptosis; 2018 Jan; 23(1):27-40. PubMed ID: 29204721
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel potent inhibitors against Bcl-xL anti-apoptotic protein using docking studies.
Shipra G; Gauri M; Chandra PM; Kishore SP
Protein Pept Lett; 2012 Dec; 19(12):1302-17. PubMed ID: 22670675
[TBL] [Abstract][Full Text] [Related]
26. Phytosterols and triterpenes from
Adewole KE; Ishola AA
J Recept Signal Transduct Res; 2019 Feb; 39(1):87-97. PubMed ID: 31215288
[TBL] [Abstract][Full Text] [Related]
27. Homology Modeling and Docking Studies of Bcl-2 and Bcl-xL with Small Molecule Inhibitors: Identification and Functional Studies.
Salam AAA; Nayek U; Sunil D
Curr Top Med Chem; 2018; 18(31):2633-2663. PubMed ID: 30659540
[TBL] [Abstract][Full Text] [Related]
28. BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.
Merino D; Kelly GL; Lessene G; Wei AH; Roberts AW; Strasser A
Cancer Cell; 2018 Dec; 34(6):879-891. PubMed ID: 30537511
[TBL] [Abstract][Full Text] [Related]
29. Therapeutics targeting Bcl-2 in hematological malignancies.
Ruefli-Brasse A; Reed JC
Biochem J; 2017 Oct; 474(21):3643-3657. PubMed ID: 29061914
[TBL] [Abstract][Full Text] [Related]
30. Small-Molecule and Peptide Inhibitors of the Pro-Survival Protein Mcl-1.
Beekman AM; Howell LA
ChemMedChem; 2016 Apr; 11(8):802-13. PubMed ID: 26696548
[TBL] [Abstract][Full Text] [Related]
31. Development of Mcl-1 inhibitors for cancer therapy.
Negi A; Murphy PV
Eur J Med Chem; 2021 Jan; 210():113038. PubMed ID: 33333396
[TBL] [Abstract][Full Text] [Related]
32. The critical role of the phytosterols in modulating tumor microenvironment via multiple signaling: A comprehensive molecular approach.
Khan AU; Khan A; Shal B; Khan S; Khan M; Ahmad R; Riaz M
Phytother Res; 2023 Apr; 37(4):1606-1623. PubMed ID: 36757068
[TBL] [Abstract][Full Text] [Related]
33. Health Benefits and Pharmacological Properties of Stigmasterol.
Bakrim S; Benkhaira N; Bourais I; Benali T; Lee LH; El Omari N; Sheikh RA; Goh KW; Ming LC; Bouyahya A
Antioxidants (Basel); 2022 Sep; 11(10):. PubMed ID: 36290632
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
